Clinafloxacin

Clinafloxacin

SCHEMBL33959

NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 1.00
POLB P06746 2/20 1.00
OPRM1 P35372 2/20 1.00
CHRM2 P08172 1/20 1.00
CHRM1 P11229 1/20 1.00
OPRD1 P41143 1/20 1.00
KCNH2 Q12809 4/20 0.61
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
TOP2A P11388 9/20 0.56
TOP2B Q02880 7/20 0.56
KDM4E B2RXH2 1/20 0.55
PRKD3 O94806 1/20 0.55
HPGD P15428 1/20 0.55
ALOX15 P16050 1/20 0.55
CLK2 P49760 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CLK4 Q9HAZ1 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
TOP1 P11387 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clinafloxacin SCHEMBL29360508 1.00 ALDH1A1 (1.00) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL8596801 1.00 ALDH1A1 (1.00) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL33960 1.00 ALDH1A1 (1.00) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL29682535 0.99 ALDH1A1 (0.98) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL5571098 0.99 ALDH1A1 (0.98) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL193234 0.99 ALDH1A1 (0.98) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL193233 0.99 ALDH1A1 (0.98) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL29288561 0.99 ALDH1A1 (0.98) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL14973954 0.98 ALDH1A1 (0.96) ALDH1A1POLBOPRM1CHRM2CHRM1
Clinafloxacin SCHEMBL8566142 0.96 ALDH1A1 (0.93) ALDH1A1POLBOPRM1CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8156 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624057-B2 Bisphosphonate quinolone conjugates and uses thereof BIOVINC, LLC (US) 2026-05-12 US claimed
US-20260108619-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2026-04-23 US claimed
EP-4434588-B1 AEROSOL DELIVERY DEVICE PARI PHARMA GMBH (DE) 2026-04-08 EP claimed
US-12576124-B2 Formulation of a conjugate of a tubulysin analog to a cell-binding molecule HANGZHOU DAC BIOTECH CO., LTD (CN) 2026-03-17 US claimed
EP-4659014-A1 EMULSION-BASED THICK-FILM ANTIFOULING COATING FOR HIGHLY SENSITIVE ELECTROCHEMICAL SENSING President And Fellows Of Harvard College (US) 2025-12-10 EP claimed
US-20250339551-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) 2025-11-06 US claimed
EP-4642492-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
EP-4642484-A1 TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
EP-4571306-A1 STABILIZING OXYGEN IN A COMPOSITION Instrumentation Laboratory Company (US) 2025-06-18 EP claimed
CN-120134696-A Clinafloxacin is low-loss forming device for suppression 南京一苇医药科技有限公司 2025-06-13 CN claimed
US-5532239-A FOR THE TREATMENT OF NEPHROTIC SYNDROMES ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) 1996-07-02 US claimed
EP-0666743-A1 SOLUBLE CALCIUM LACTATE/QUINDONECARBOXYLIC ACIDS ON NAPHTHYDRINECARBOXYLIC ACIDS COMPLEXES AS NON-IRRITATING PARENTERAL FORMS WARNER-LAMBERT COMPANY (US) 1995-08-16 EP claimed
WO-1994009779-A1 SOLUBLE CALCIUM LACTATE/QUINDONECARBOXYLIC ACIDS ON NAPHTHYDRINECARBOXYLIC ACIDS COMPLEXES AS NON-IRRITATING PARENTERAL FORMS WARNER-LAMBERT COMPANY (US) 1994-05-11 WO claimed
US-5290794-A Storage stable compositions WARNER LAMBERT CO. (US) 1994-03-01 US claimed
US-5188833-A Antibacterial quinolinecarboxylic acid derivatives; photostability, heat resistance KYORIN SEIYAKU KABUSHIKI KAISHA (JP) 1993-02-23 US claimed
EP-0322892-B1 FREEZE-DRIED PHARMACEUTICAL PREPARATIONS FOR PARENTERAL USE KYORIN SEIYAKU KABUSHIKI KAISHA (JP) 1992-03-25 EP claimed
CN-1035507-A The freeze-dried pharmaceutical preparations that parenteral uses KYORIN SEIYAKU KK (JP) 1989-09-13 CN claimed
EP-0322892-A1 Freeze-dried pharmaceutical preparations for parenteral use KYORIN SEIYAKU KABUSHIKI KAISHA (JP) 1989-07-05 EP claimed
US-4771054-A QUINOLINE CARBOXYLIC ACID WARNER-LAMBERT COMPANY (US) 1988-09-13 US claimed
EP-0167763-B1 7-AMINO-1-CYCLOPROPYL-6,8-DIHALO-1,4-DIHYDRO-4-OXO-3-QUINOLINE-CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND BACTERICIDAL AGENTS CONTAINING THEM BAYER AG (DE) 1988-08-03 EP claimed